1
|
Short R, Greenwade M, Bonebrake A. Yolk sac tumor presenting as a colonic mass in a post-menopausal woman: A case report. Gynecol Oncol Rep 2022; 42:101038. [PMID: 35832044 PMCID: PMC9272345 DOI: 10.1016/j.gore.2022.101038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/18/2022] [Revised: 06/27/2022] [Accepted: 06/28/2022] [Indexed: 11/28/2022] Open
Abstract
Yolk sac tumors are quite rare in post-menopausal women. Yolk sac tumors with endometrial primary origin also may present with abnormal uterine bleeding. Patients with unclear abdominal symptoms, mass on imaging, and positive tumor markers raises suspicion of yolk sac tumor.
Collapse
Affiliation(s)
- R Short
- University of Missouri-Columbia School of Medicine, Columbia, MO, USA
| | | | | |
Collapse
|
2
|
Zamorano A, Greenwade M, Mullen M, Huepenbecker S, Cripe J, Dandulakis M, Thaker P, Powell M, Mutch D, Kuroki L. Geographic disparities and postoperative complications in ovarian cancer surgery. Gynecol Oncol 2020. [DOI: 10.1016/j.ygyno.2020.05.425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
3
|
McKinnish T, Greenwade M, Rosenthal E, Wilkinson-Ryan I, Schwarz J, Powell M, Mutch D, Thaker P. Management and outcomes of partial metabolic response on post-therapy positron emission tomography in cervical cancer patients treated with definitive radiation. Gynecol Oncol 2020. [DOI: 10.1016/j.ygyno.2020.05.253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
4
|
Essel K, Vetter M, Doo D, Greenwade M, Vesely S, Evans E, Strope B, Opara G, Powell M, Arend R, Salani R, Moore K. Prognostic factors associated with survival following platinum based therapy in advanced/recurrent endometrial cancer. Gynecol Oncol 2019. [DOI: 10.1016/j.ygyno.2019.03.212] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
5
|
Mullen M, Quinn J, Greenwade M, Opara G, Beck-Noia H, Hagemann I, Hagemann A, Kuroki L, McCourt C, Thaker P, Powell M, Mutch D, Fuh K. AXL in metastatic ovarian cancer tumors is a targetable biomarker associated with chemoresistance and poor prognosis. Gynecol Oncol 2019. [DOI: 10.1016/j.ygyno.2019.04.188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
6
|
Essel K, Vetter M, Doo D, Greenwade M, Machiorlatti M, Evans E, Strope B, Opara G, Vesely S, Powell M, Arend R, Salani R, Moore K. Prognostic factors associated with survival following platinum-based therapy in advanced/recurrent endometrial cancer. Gynecol Oncol 2019. [DOI: 10.1016/j.ygyno.2019.04.550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
7
|
Greenwade M, Palisoul M, Mutch D, Hagemann A, McCourt C, Thaker P, Fuh K, Powell M, Kuroki L. Factors associated with obstetric and gynecology residents’ decision to pursue fellowship. Gynecol Oncol 2019. [DOI: 10.1016/j.ygyno.2019.04.532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
8
|
Kuroki L, Landon M, Leon A, Hagemann A, McCourt C, Dick R, Greenwade M, Thaker P, Fuh K, Powell M, Mutch D, Vanderlan J. Integrated psychological care in gynecologic oncology outpatient clinics: A feasibility study. Gynecol Oncol 2019. [DOI: 10.1016/j.ygyno.2019.04.666] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
9
|
Greenwade M, Landon M, Vanderlan J, Leon A, Dick R, Hagemann A, Thaker P, Fuh K, McCourt C, Powell M, Mutch D, Kuroki L. NCCN distress thermometer underscores unmet psychological needs. Gynecol Oncol 2019. [DOI: 10.1016/j.ygyno.2019.04.664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
10
|
Greenwade M, Grither W, Hagemann A, McCourt C, Mutch D, Powell M, Thaker P, Fuh K. Stromal cell expression of the receptor tyrosine kinase DDR2 promotes ovarian cancer metastasis. Gynecol Oncol 2018. [DOI: 10.1016/j.ygyno.2018.04.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
11
|
Crim A, Rowland M, Ruskin R, Dvorak J, Greenwade M, Walter A, Gillen J, Ding K, Moore K, Gunderson C. Evaluation of the efficacy and toxicity profile associated with intraperitoneal chemotherapy use in older women. Gynecol Oncol 2017; 146:268-272. [PMID: 28583323 DOI: 10.1016/j.ygyno.2017.05.032] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2017] [Revised: 05/11/2017] [Accepted: 05/24/2017] [Indexed: 11/17/2022]
Abstract
OBJECTIVE Intraperitoneal (IP) chemotherapy (CT) for treatment of epithelial ovarian cancer (EOC) has been shown to provide a substantial OS advantage. This study aims to compare the toxicity and benefits of IP CT in patients ≥70 with those <70. METHODS We performed a single institution retrospective review of patients diagnosed with Stage IIA-IIIC EOC from 2000 to 2013 who received IP CT. Clinicopathologic characteristics were extracted, and survival was calculated. RESULTS 133 patients were included with 100 pts. <70years old and 33 pts. ≥70years old. Clinical trial enrollment was similar despite age. In trial enrolled patients, older patients received statistically fewer cycles of therapy (6.4 vs 5.8, p=0.002) but had similar dose delays (0.9 vs 0.7, p=0.72), and modifications (0.9 vs 0.36, p=0.11). Median PFS (27 vs 31months) and OS (71 and 62months) were not statistically different. Grade 3/4 neutropenia was significantly worse in the older patients (82% vs 100%, p=0.04). Neuropathy grade ≥2 and other non-hematologic toxicities were not different between age groups. CONCLUSIONS Despite completing fewer cycles of IP CT, older EOC patients had comparable survival to younger patients. The population of older patients receiving IP CT in this study were on clinical trial and likely to be heartier than the general older population. IP CT appears well tolerated and effective among select older patients and is likely under-utilized outside of clinical trials.
Collapse
Affiliation(s)
- A Crim
- Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma, Oklahoma City, OK, USA.
| | - M Rowland
- Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma, Oklahoma City, OK, USA.
| | - R Ruskin
- Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma, Oklahoma City, OK, USA.
| | - J Dvorak
- Department of Biostatistics and Epidemiology, University of Oklahoma, Oklahoma City, OK, USA.
| | - M Greenwade
- Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma, Oklahoma City, OK, USA.
| | - A Walter
- Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma, Oklahoma City, OK, USA.
| | - J Gillen
- Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma, Oklahoma City, OK, USA.
| | - K Ding
- Department of Biostatistics and Epidemiology, University of Oklahoma, Oklahoma City, OK, USA.
| | - K Moore
- Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma, Oklahoma City, OK, USA.
| | - C Gunderson
- Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma, Oklahoma City, OK, USA.
| |
Collapse
|
12
|
Crim A, Greenwade M, Chen S, Mannel R, McMeekin S, Moore K, Holman L. Prevalence of Lynch Syndrome-Associated Tumors in Minority Patients with Endometrial Cancer. Gynecol Oncol 2016. [DOI: 10.1016/j.ygyno.2016.08.285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
13
|
Greenwade M, Gunderson C, Ramkisson S, Ali S, Vergilio J, Suh J, Ross J, Elvin J, Moore K. Uterine Carcinosarcoma: Molecular Profiling and Identification of Possible Therapeutic Targets. Gynecol Oncol 2016. [DOI: 10.1016/j.ygyno.2016.08.255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
14
|
Elvin J, Gay L, Gunderson C, Greenwade M, Ramkissoon S, Ali S, Vergilio JA, Suh J, Ross J, Moore K. Comprehensive genomic profiling of uterine carcinosarcomas identifies potential targeted therapy opportunities. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw374.41] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
15
|
Greenwade M, Rowland M, Ruskin R, Ding K, Gillen J, Crim A, Walter A, Kleis B, Moore K, Gunderson C. Factors influencing clinical trial enrollment among ovarian cancer patients. Gynecol Oncol 2016. [DOI: 10.1016/j.ygyno.2016.04.332] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
16
|
Rowland M, Ruskin R, Dvorak J, Gunderson C, Walter A, Crim A, Gillen J, Greenwade M, Ding K, Moore K. Exploring further the poor outcomes of elderly patients with platinum-sensitive recurrent ovarian cancer using a contemporary application of the SOCRATES study. Gynecol Oncol 2016. [DOI: 10.1016/j.ygyno.2016.04.460] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
17
|
Crim A, Rowland M, Ruskin R, Dvorak J, Greenwade M, Walter A, Gillen J, Ding K, Moore K, Gunderson C. Is intraperitoneal chemotherapy as effective within the elderly population for the treatment of epithelial ovarian cancer? Gynecol Oncol 2016. [DOI: 10.1016/j.ygyno.2016.04.304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
18
|
Rowland M, Ruskin R, Greenwade M, Moore K, Matzo M. The treatment is over, but the symptoms remain in gynecologic oncology cancer patients. Gynecol Oncol 2016. [DOI: 10.1016/j.ygyno.2016.04.370] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|